Recombinant interferon-alpha 2b and megestrol acetate in patients with advanced renal cell carcinoma

Journal of the Medical Association of Thailand

Volumn 83, Issue 2, 2000, Pages 123-128

  Voravud, Narin ^a   Sriuranpong, Viroj ^a   Lertsaguansinchai, Prasert ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Anorexia; Interferon; Kidney neoplasms; Megestrol acetate

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; MEGESTROL ACETATE; RECOMBINANT ALPHA2B INTERFERON;

AGED; ANEMIA; ANOREXIA; ARTICLE; CACHEXIA; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; FLU LIKE SYNDROME; HUMAN; KIDNEY CARCINOMA; LIVER DYSFUNCTION; MALE; METASTASIS; NAUSEA; NEUTROPENIA; PAIN; PHASE 2 CLINICAL TRIAL; PROTEINURIA; THROMBOCYTOPENIA; TREMOR; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INTERFERON ALFA-2B; KIDNEY NEOPLASMS; MALE; MEGESTROL ACETATE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034061134     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Linehan WM, Shiplely WU, Longo DL. Cancer of the kidney and ureter. Cancer Principles and Practices of Oncology 3rd ed. In DeVita VT Jr, Helman S, Rosenberg SA (eds): Philadelphia, J.B. Lippincott 1989:979-1007.
2. Torti FM. Treatment of metastatic renal cell carcinoma. Recent results Cancer Res 1983;85: 123-42.
3. Quesada JR, Swanson DA, Trindade A, Trindade A, Gutterman JU. Renal cell carcinoma: Antitumor effects of leukocyte interferon. Cancer Res 1983; 43:940-7.
4. Krown SE, Einzig AI, Abramson JD, Oettgen MF: Treatment of advanced renal cell cancer with recombinant leukocyte A interferon. Proc Am Soc Clin Oncol 1983;2:58 (abstr).
5. deKernion JB, Sarna G, Figlin R, Linder A, Smith RB. The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol 1983;130:1063-6.
6. Trump D, Harris J, Tuttle R, et al. Phase II trial of high dose human lymphoblastic interferon (Welferone) in advanced renal cell caricnoma (aRCC). Proc Am Soc Clin Oncol 1985;3:153 (abstr).
7. Kempf RA, Grunberg SM, Daniels JR, et al. Recombinant interferon alpha-2a (Intron A) in a phase II study of renal cell carcinoma. J Biol Respone Mod 1986;5:27-35.
8. Kirkwood JM, Haris JE, Vera R, et al. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: The American Cancer Society Collaborative Trial. Cancer Res 1985;45:863-71.
9. Vurgrin D, Hood L, Taylor W, Laszlo J. Phase II study of human lymphoblastoid interferon in patients with advanced renal cell carcinoma. Cancer Treat Rep 1985;69:817-20.
10. Neidhart JA, Gagen MM, Young D, et al. Interferon-alpha therapy for advanced renal cell carcinoma. Cancer Res 1984;44:4140-3.
11. Marumo K, Murai M, Hayakawa M, et al. Human lymphoblastoid interferon therapy for advanced renal cell carcinoma. Urology 1984;24:567-71.
12. Aisner J, Tchekmedyian NS, Moody M, Tait N. High-dose megestrol acetate for the treatment of advanced breast cancer; dose and toxicities. Semi Hematol 1987;242:48-55.
13. Bloom HJG, Dukes CE, Mitchley BCV. Hormone dependent tumors of the kidney: I. The Oestrogen-Induced Renal Tumor of the Syrian Hamster; Hormone Treatment and Possible Relationship to Carcinoma of the Kidney in Man. Br J Cancer 1963;17:611.
14. Bloom HJG, Baker WH, Dukes CE, Mitchey BCV. Hormone-dependent tumors of the kidney: II. Effect of endocrine ablation procedures on the transplanted oestrogen-induced renal tumor of the Syrian hamster. Br J Cancer 1963;17:646.
15. Bloom HJG, Roe FJC, Mitchley BCV. Sex hormones and renal neoplasia. Cancer 1967;20:2118.
16. Bloom HJG. Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer 1973;32:1066-71.
17. Steineck GH, Strander HB, Carbin E, et al. Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma: A randomized trial. Acta Oncol 1990;29: 155-62.
18. Steineck GH, Strander H, Carbin Be, et al. Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma: A randomized trial. Acta Oncol 1990;29:155-62.
19. Spiegel RJ. Alpha interferon: A clinical overview. Urology 1989;34:75-9.
20. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity in cancer patients: A review. J Clin Oncol 1986;4:234-43.
21. Loprinzi CL, Ellison NM, Schaid DJ, et al. A controlled trial of megestrol acetate for the treatment ofcancer anorexia and cachexia. J Natl Cancer Inst 1990;82:1127-32.
22. Hamburger AW, Parnes H, Gordon GB, et al. Megestrol acetate induced differentiation of 3 T3-L1 adipocytes in vitro. Semin Oncol 1988;15(2 Suppl 1)76-8.